Skip to content
healthcare.dev

TREMFYA

NDC 57894-650, Guselkumab, injection, from Janssen Biotech, Inc..

Product NDC
57894-650
Status
Listed
Labeler
Janssen Biotech, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761061
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57894-650 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUSELKUMAB200 mg/20mL

Pharmacologic classes

Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
57894-650-02578940650021 VIAL, SINGLE-DOSE in 1 CARTON (57894-650-02) / 20 mL in 1 VIAL, SINGLE-DOSE (57894-650-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1e6dc9ae-1c4c-42d9-87aa-c315ecc51b56
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=57894-650

Use it

Look up 57894-650 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57894-650 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57894-650. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.